Market News AIOpen the app

Baird raised its price target for Charles River Laboratories to $365, up from $364.

OpinionRead the original at marketscreener.com
Neutral

Baird's target rose by $1, but the source calls this routine coverage and reports no change to CRL's operations or plans. It does not change the company's outlook.

CRL · Charles River Laboratories International, Inc.

AI read · Neutral

The AI's read

That change is only in Baird's estimate, not in CRL's operations. The source calls it routine coverage and reports no change to the company's business or plans.

Get alerts for CRL

Follow Charles River Laboratories International, Inc. (CRL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CRL
Free on the App Store and Google Play, or on the web.